Scholarly Index
Kena A. Swanson
Pfizer (United States); 30,246 total citations; 106 total publications; best world rank #70
Pfizer (United States)
30,246Total citations
106Total publications
39H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Respiratory viral infections research | 2021-2025 | 70 | US 34 | 98.29 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 686 | US 216 | 97.28 |
| Pneumonia and Respiratory Infections | 2021-2025 | 335 | US 98 | 93.55 |
| SARS-CoV-2 detection and testing | 2021-2025 | 505 | US 120 | 91.59 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 767 | US 238 | 89.98 |
| Parvovirus B19 Infection Studies | 2021-2025 | 429 | US 117 | 68.80 |